TG Therapeutics has started enrolling participants in a Phase 3 trial to test a new version of Briumvi (ublituximab-xiiy) that can be injected at home. This change could offer greater […]
The post Phase 3 trial begins for at-home injectable version of Briumvi appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com